Menu Menu Menu Menu
To Top

Search By Topic

Drug Delivery

43 Articles available
Drug Delivery

The Chemistry Inside Innovation

Donald Loveday, Ph.D., Customer Applications Director, Pharma and Medical, Celanese

PTV-M06-17-BIO-001
Drug Delivery

The Future Of Uniquely Delivered Drugs and ADCs

MCP-M07-17-NI-020
Drug Delivery

Harvard University Researchers Develop Ultrasound/Nanoparticle Method for Targeted Delivery of Chemotherapeutics

PAO-M06-17-NI-015
Drug Delivery

Unither Pharmaceuticals on the Road to BIO: Innovation in Delivery

David Kudla, General Manager for North America, Unither Pharmaceuticals. View more about Unither Pharmaceuticals on the Road to BIO.

PTV-M06-17-CL-002
Excipients

Celanese on the Road to BIO: Excipients In Biologics

Dr. Donald Loveday – Customer Applications Director, Pharma and Medical, Celanese. View more about Celanese on the Road to BIO.

PTV-M06-17-CL-010
Drug Delivery

Vetter and Microdermics Will Develop Microneedle Delivery Systems

PAO-M06-17-NI-008
Regulatory

Moving Quality to the Forefront Brings Measurable Results

PAP-Q2-17-CL-008
Drug Delivery

The Search for Alternative Delivery Methods Continues

PAP-Q2-17-FA-003
Drug Delivery

The People’s Choice: Premeasured Single Dosage Forms

PAP-Q2-17-CL-014
Drug Delivery

Trends in the Topical Delivery of Dermatology Medications

MCM-M05-NI-001
Biologics

Dan Peizer Reveals Catalant’s Newest Acquisition

Dan Peizer, Global Director of Corporate Marketing, Catalent

PTV-M11-16-AP-027
Formulation

Focusing on Patient Compliance

Brian Wilson, Technical Development Manager, SPI Pharma

PTV-M01-17-NS-011
Innovation

The Latest Developments at Triskelion

Tineka Meijers, VP, Business Development, Triskelion, TNO Predictive Health Technologies

PTV-M11-16-AP-004
Formulation

Innovative Drug Delivery Technology

Kevin Haehl, General Manager, North America, Unither Pharmaceuticals

PTV-M11-16-AP-006
Drug Delivery

Breakthrough Drug Delivery Technology

Tobias Bachle, Sales Director, Pantec Biosolutions

PTV-M11-16-AP-022
Discovery

New Ventures in the Microbiome

PAP-Q1-17-TT-001
CDMO

Pharma’s Reputation Gap: Consumer Business Innovation

PAP-Q1-17-CL-009
API

Achieving Security of Supply with Effective Particle Engineering

PAP-Q1-17-CL-002
Equipment

Stay Tuned: Pharma’s Almanac TV Goes Live

PAP-Q1-17-PT-001
CDMO

Human Factors Engineering and the Variability of the Human Condition

APR-M02-17-NI-001
Drug Delivery

Advances in Delivering Protein and Peptide Therapeutics

PTO-M11-16-NI-001
Excipients

What’s New at AAPS: Materials

PAP-M11-16-NI-001
API

A Look at Recent Pharma Industry Innovations

PAP-Q04-16-NO-001
Formulation

Better Design, Better Outcomes, Better Economics

PAP-Q04-16-IL-001
API

Dry-Powder Inhalation Formulation: Balancing Performance and Manufacturability

PAP-Q04-16-CL-006
API

Capsugel’s Transformation: Q&A with Guido Driesen

PAP-Q04-16-QA-001
Packaging

Advancing Patient-Centric Parenteral Drug Strategies

PAP-Q04-16-CL-001
CDMO

Patient-Centric Drug Development: Designing Medicines to Succeed

PAP-Q03-16-CL-004
API

Embracing Formulation Expertise to Extend Exclusivity & Improve the Patient Experience

PAP-Q03-16-CL-005
Clinical Trials

Dose and Form Matter: Future of Care Demands Optimal Drug Delivery

PAP-Q02-16-CL-003
Excipients

Optimising Excipients to Improve Bioavailability

MCP-M03-16-NI-001
CDMO

The Importance of Convenient Dosing Formulations for Elderly Patients

PAP-Q1-16-CL-008
API

Patient Safety and Parenteral Delivery Systems

PAP-Q1-16-CL-010
API

Strong CMO/CDMO Market Outlook for 2016, but Beware Moderating Factors

PAP-Q1-16-FA-001
API

Bolstering Capabilities for Parenteral Drug Development and Manufacturing

PAP-Q4-15-CL-005
Patient Adherence

Why Innovative Drug Delivery Packaging Solutions Are Needed for Today’s Patients

PAP-APR-S01-CL-003
Biologics

Pre-filled Syringe Technology Benefits Patients, Healthcare Providers and Drug Makers

CIO-M06-14-NI-001
CDMO

New Technologies In Fill-Finish May Bring Brand Loyalty Along with Improved Patient Safety

LSL-M04-14-NI-001
Biologics

CROs and CMOs Continuing Drug Delivery Innovation

CIO-M08-13-NI-001
Formulation

Outsourcing and the Oral Solid Dose: Will Challenges Lead to New Patterns of Outsourcing?

CIO-M06-13-NI-001
Outsourcing

Outsourcing Trends for 2012 — Top Services by Customer Segment and the Prevalence of Contracting to Emerging Markets

GXP-M02-12-NI-001
Outsourcing

What CROs and CMOs Can Learn from Q3 Outsourcing Data and 2011 Trends

PQO-M11-11-NI-001
CMO

Sterile Manufacturing Opportunities

PPO-M10-11-NI-001
//Fix for text overflow in cards